Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 704 | 620 | 547 | N/A | 869 |
| Accounts receivable | -467 | -381 | -60 | 87 | -459 |
| Other Working Capital | -1,918 | -1,969 | 1,161 | 149 | -211 |
| Other Operating Activity | -10,158 | -10,648 | 14,611 | -9,351 | -12,467 |
| Operating Cash Flow | $-11,839 | $-12,378 | $16,259 | $-9,115 | $-12,268 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 12 | -842 | -391 | -123 | -222 |
| Net Acquisitions | 1,394 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -79 |
| Investing Cash Flow | $1,406 | $-842 | $-391 | $-123 | $-301 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,085 | -77 | -243 | N/A | N/A |
| Common Stock Issued | 48 | 84 | 11,704 | 1,115 | 23,854 |
| Common Stock Repurchased | N/A | N/A | N/A | -630 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 1,924 | -675 |
| Financing Cash Flow | $-3,037 | $7 | $11,461 | $2,409 | $23,179 |
| Exchange Rate Effect | -75 | -620 | -446 | 257 | -32 |
| Beginning Cash Position | 28,269 | 42,102 | 15,219 | 21,791 | 11,213 |
| End Cash Position | 14,724 | 28,269 | 42,102 | 15,219 | 21,791 |
| Net Cash Flow | $-13,470 | $-13,213 | $27,329 | $-6,829 | $10,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,839 | -12,378 | 16,259 | -9,115 | -12,268 |
| Capital Expenditure | -161 | -842 | -391 | -151 | -222 |
| Free Cash Flow | -12,000 | -13,220 | 15,868 | -9,266 | -12,490 |